Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study

The purpose of this study was to evaluate the effectiveness of intravitreal ranibizumab (Lucentis, Genentech, South San Francisco, Calif, USA) combined with cataract surgery for the prevention of clinically significant macular edema (CSME) in patients with diabetic retinopathy (DR). This prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Udaondo, Patricia, Garcia-Pous, Maria, Garcia-Delpech, Salvador, Salom, David, Diaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136100/
https://www.ncbi.nlm.nih.gov/pubmed/21772983
http://dx.doi.org/10.1155/2011/159436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136100/
https://www.ncbi.nlm.nih.gov/pubmed/21772983
http://dx.doi.org/10.1155/2011/159436

Ejemplares similares